- Home
- Software Solutions
- Resources
- Corporate
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Female | |
Names:
| Enrollment: 38 | |
Additional information about NCT00513786.